PRGO

Perrigo Company PLC

PRGO, USA

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

https://www.perrigo.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

Quarterly

Rate:

0.29

Next Payout:

Dec 16, 2025

Yield:

8.8314 %
PRGO
stock
PRGO

Perrigo (PRGO) Valuation Revisited After Class Action Lawsuits Over Infant Formula Disclosures simplywall.st

Read more →
PRGO
stock
PRGO

PRGO INVESTOR DEADLINE: Perrigo Company plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit marketscreener.com

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$21.5

Analyst Picks

Strong Buy

1

Buy

2

Hold

2

Sell

0

Strong Sell

0

Sentiment:

Neutral

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.41

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

0.17 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

0.07 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

2.86 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.27

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 106.33% of the total shares of Perrigo Company PLC

1.

T. Rowe Price Associates, Inc.

(10.5778%)

since

2025/06/30

2.

Vanguard Group Inc

(10.1954%)

since

2025/06/30

3.

BlackRock Inc

(9.5419%)

since

2025/06/30

4.

T. Rowe Price Mid-Cap Value

(6.1658%)

since

2025/07/31

5.

T. Rowe Price US Mid-Cap Value Equity

(5.9686%)

since

2025/06/30

6.

Dimensional Fund Advisors, Inc.

(5.461%)

since

2025/06/30

7.

State Street Corp

(5.3352%)

since

2025/06/30

8.

DePrince Race & Zollo Inc

(3.3155%)

since

2025/06/30

9.

T. Rowe Price U.S. Mid-Cap Val Eq Tr-D

(3.2855%)

since

2025/06/30

10.

iShares Core S&P Mid-Cap ETF

(3.2525%)

since

2025/08/31

11.

Vanguard Total Stock Mkt Idx Inv

(3.1308%)

since

2025/07/31

12.

Ion Asset Management Ltd.

(2.7748%)

since

2025/06/30

13.

Neuberger Berman Group LLC

(2.6971%)

since

2025/06/30

14.

Vanguard Small Cap Index

(2.4259%)

since

2025/07/31

15.

Cooke & Bieler LP

(2.3979%)

since

2025/06/30

16.

Sound Shore Management Inc

(2.3896%)

since

2025/06/30

17.

Geode Capital Management, LLC

(1.7842%)

since

2025/06/30

18.

Thompson, Siegel & Walmsley LLC

(1.6895%)

since

2025/06/30

19.

Copeland Capital Management, LLC

(1.6357%)

since

2025/06/30

20.

Vanguard Small Cap Value Index Inv

(1.5631%)

since

2025/07/31

21.

Wellington Management Company LLP

(1.455%)

since

2025/06/30

22.

Bahl & Gaynor Inc.

(1.4386%)

since

2025/06/30

23.

Perpetual Ltd

(1.3944%)

since

2025/06/30

24.

DFA US Small Cap Value I

(1.3431%)

since

2025/07/31

25.

T. Rowe Price Investment Management,Inc.

(1.3338%)

since

2025/06/30

26.

Diamond Hill Capital Management Inc

(1.2032%)

since

2025/06/30

27.

Amvescap Plc.

(1.1326%)

since

2025/06/30

28.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0723%)

since

2025/07/31

29.

BW Gestao de Investimentos Ltda

(1.0681%)

since

2025/06/30

30.

SPDR® S&P Dividend ETF

(1.0193%)

since

2025/08/31

31.

Neuberger Berman Glb Eq Mgtrnd USD IAcc

(1.0057%)

since

2025/07/31

32.

Bahl & Gaynor Sm/Md Cp Inc Gr ETF

(0.9982%)

since

2025/08/29

33.

ProShares S&P MidCap 400 Dividend Arst

(0.9027%)

since

2025/08/29

34.

Vanguard Selected Value Inv

(0.873%)

since

2025/06/30

35.

Diamond Hill Long-Short Inv

(0.8453%)

since

2025/08/31

36.

SPDR® S&P MIDCAP 400 ETF Trust

(0.7654%)

since

2025/07/31

37.

DFA US Targeted Value I

(0.7464%)

since

2025/07/31

38.

Sound Shore Investor

(0.7391%)

since

2025/06/30

39.

ROPS Actions US 1

(0.7268%)

since

2025/07/31

40.

Diamond Hill Small-Mid Cap Equity

(0.6791%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

1.04

Latest Release

Date

2025-09-30

EPS Actual

0.8

EPS Estimate

0.76

EPS Difference

0.04

Surprise Percent

5.2632%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(8.5)
Defensive
Highly Defensive(7.5)
Dividend
Decent Dividend Payer(4.5)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(3)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(4)
Value
Undervalued(7)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.